Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1995-06-06
1997-12-23
Schain, Howard E.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
514 3, C07K 740, D61K 3726
Patent
active
057006628
ABSTRACT:
Recombinant processes for preparing insulin analogs modified at position 29 of the B-chain and, optionally, at other positions are claimed. The analogs produced using the claimed processes have modified physico-chemical properties and are useful in treating hyperglycemia.
REFERENCES:
patent: 4639333 (1987-01-01), Obermeier et al.
patent: 4946828 (1990-08-01), Markussen et al.
patent: 5164366 (1992-11-01), Balschmidt et al.
patent: 5514646 (1996-05-01), Chance et al.
Randle, P.J., Assay of Plasm Insulin Activity by the Rat-Diaphragm Method, Brit. Med. J. 1:1237 (1954).
Steinke, J. et al., Assay of Crystalline Insulin and of Serum Insulin-Like Activity of Different Species on Adipose Tissue of the Rat, Mouse and Guinea Pig, N.E.J. Med. 273:1464 (1965).
Sheps, M.C. et al., Measurement of Small Quantities of Insulin-Like Activity Using Rat Adipose Tissue. II. Evaluation of Performance, J. Clin. Investigation 39:1499 (1960).
Burke, G.T. et al., Superactive Insulins, Biochem. Biophys. Res. Comm. 173:982 (1990).
Brange, J. et al., Monomeric Insulins and Their Experimental and Clinical Implications, Diabetes Care 13:923 (1990).
Bruce H. Frank, Text and Slide Copies of Lecture given at the Conference on Insulin, Self Association and Conformational Studies on Human Proinsulin and Insulin Analogs, University of York, Aug. 29-Sep. 1, 1989.
J. Brange, et al., Monomeric Insulins Obtained by Protein Engineering and their Medical Implications, Nature 333:679 (1988).
J. Brange, et al., 65. Insulin Analogues with Reduced Association Tendency: Biological Activity and Absorption Rate After Subcutaneous Administration, Abstracts, 503A.
Rinderknecht E., et al, The Aminor Acid Sequence of Human Insulin-like Growth Factor I and Its Structural Homology with Proinsulin, J. Biol. Chem., 253:8, 2769-2776 (1978).
Brange, et al, Monomeric Insulins by Protein Eingineering, Protein Engineering, 1:3, 238, Abstract No. 3.
Brange, et al, Insulin Analogues with Reduced Assocation Tendency; Biological Activity and Absorption Rate After Subcutaneous Administration, PostGrad, Med. J. 64:3, 18 (1988).
Chance Ronald E.
DiMarchi Richard D.
Frank Bruce H.
Shields James E.
Boone David E.
Eli Lilly and Company
Maciak Ronald S.
Schain Howard E.
LandOfFree
Process for preparing insulin analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preparing insulin analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing insulin analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1801901